Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksAUROLAB
resources
AUROLAB

Auro Laboratories Ltd.

BSE: 530233
Sector: Healthcare
Industry: Pharmaceuticals
219.00+4.5 (+2.10%)
23 Oct, 3:30 PM

Annual Reports and Financial Documents

Auro Laboratories Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Quarterly Results—————
Conference Calls——————————————
Presentations——————————————

Corporate Announcements and Regulatory Filings

Auro Laboratories Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201813 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Auro Laboratories Limited has submitted the Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026.
  2. Closure of Trading Window23 Sept 2026
    Closure of Trading Window
    Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 we wish to inform you that, the trading window for dealing in the securities of the company will remain closed w.e.f. ....
  3. Newspaper Publication17 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Auro Laboratories Limited has submitted the clippings of newspaper publications of the Un-audited Financial Results for the quarter ended June 30, 2026.
  4. Outcome of Board Meeting14 Aug 2026
    Board Meeting Outcome for Outcome Of Board Meeting Held On August 14, 2026.
    Auro Laboratories Limited has submitted the Outcome of the Board Meeting held on August 14, 2026
  5. AGM13 Aug 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Auro Laboratories Limited has submitted the Scrutinizer Report of 37th AGM held on August 11, 2026.
  6. AGM11 Aug 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Auro Laboratories Limited has submitted the Proceedings/Outcome of the 37th Annual General Meeting held on August 11, 2026.
  7. Board Meeting10 Aug 2026
    Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30, 2026.
    Auro Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
  8. Newspaper Publication20 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    With reference to Regulation 47 of SEBI (LODR) Regulations 2015, attached herewith newspaper cuttings of Public Notice of the 37th AGM, information on evoting and other related information.
  9. General16 Jul 2026
    Regulation 36(1)(B) Of SEBI (LODR) Regulations, 2015
    The Letter being send to the shareholders containing the web-link of the Annual Report of the Company for the FY 2025-2026 is enclosed.
  10. Reg. 34 (1) Annual Report16 Jul 2026
    Reg. 34 (1) Annual Report.
    Enclosed Annual report of the Company for the FY 2025-2026
  11. AGM16 Jul 2026
    Notice Of 37Th Annual General Meeting (AGM) Scheduled On Tuesday, August 11, 2026
    Enclosed Notice of 37th Annual General Meeting of the Company scheduled on August 11, 2026 at 11:30a.m. (IST)
  12. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201815 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Auro Laboratories Limited has submitted the Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2026.
  13. Newspaper Publication15 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Auro Laboratories Limited has submitted the Newspaper Publication regarding intimation of 37th AGM of the Company.
  14. Change in Management30 Jun 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Auro Laboratories Limited hereby approve the re-appointment of Mr. Kiran Suresh Kulkarni as a Whole Time Director.
  15. Outcome without intimation30 Jun 2026
    Board Meeting Outcome for Outcome Of The Board Meeting Dated June 30, 2026
    Auro Laboratories Limited scheduled the Board Meeting on June 30, 2026 to transact the business matter which are attached herewith.
  16. Closure of Trading Window26 Jun 2026
    Closure of Trading Window
    Auro Laboratories Limited has informed about the Closure of Trading Window.
  17. Newspaper Publication1 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Enclosed herewith Newspaper Advertisement
  18. Reg.24(A)-Annual Secretarial Compliance29 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Enclosed herewith Annual Secretarial Compliance Report for the Year Ended March 31, 2026.
  19. Change in Management29 May 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Enclosed herewith appointment of Chief Financial Officer, Tax Auditor, Internal Auditor and Reappointment of Cost Auditor.
  20. Outcome of Board Meeting29 May 2026
    Board Meeting Outcome for Held On May 29, 2026
    Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we wish to inform you that the Board of Directors of the Company ....

Frequently Asked Questions

Where can I download the annual report of Auro Laboratories Ltd.?
Annual reports of Auro Laboratories Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Auro Laboratories Ltd.?
Quarterly earnings results and presentations of Auro Laboratories Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Auro Laboratories Ltd. publish earnings call transcripts?
Earnings call transcripts of Auro Laboratories Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Auro Laboratories Ltd.?
Investor presentations and annual day presentations of Auro Laboratories Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Auro Laboratories Ltd.?
Corporate announcements and regulatory filings of Auro Laboratories Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Auro Laboratories Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Auro Laboratories Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Auro Laboratories Ltd.?
The ISIN (International Securities Identification Number) of Auro Laboratories Ltd. is INE292C01011. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Auro Laboratories Ltd. listed?
Auro Laboratories Ltd. is listed on NSE and BSE. The NSE symbol is AUROLAB and the BSE code is -.
Where can I find the shareholding pattern of Auro Laboratories Ltd.?
The quarterly shareholding pattern of Auro Laboratories Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Auro Laboratories Ltd. on Sharpely?
Share price data for Auro Laboratories Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.